AbbVie launches Produodopa for treatment of parkinson's disease in EU
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Sonoma will manufacture Ocudox by Avenova with packaging similar to NovaBay’s Avenova products
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
His most recent stint was with Danone India as its Managing Director
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
Subscribe To Our Newsletter & Stay Updated